Hologic Inc
NASDAQ:HOLX
Hologic Inc
Operating Income
Hologic Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Hologic Inc
NASDAQ:HOLX
|
Operating Income
$904.3m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Income
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$2.4B
|
CAGR 3-Years
39%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
Stryker Corp
NYSE:SYK
|
Operating Income
$4.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Income
$6.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$1.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
See Also
What is Hologic Inc's Operating Income?
Operating Income
904.3m
USD
Based on the financial report for Dec 30, 2023, Hologic Inc's Operating Income amounts to 904.3m USD.
What is Hologic Inc's Operating Income growth rate?
Operating Income CAGR 10Y
13%
Over the last year, the Operating Income growth was -29%. The average annual Operating Income growth rates for Hologic Inc have been -22% over the past three years , 12% over the past five years , and 13% over the past ten years .